Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Background: Allergen-specific subcutaneous immunotherapy is an effective treatment for certain allergic disorders. Ideally, it should be administered into the subcutaneous space in the mid-posterolateral upper arm. Injections are commonly given using a standard allergy syringe with a needle length of 13 mm. Therefore, there is a risk of intramuscular administration if patients have a skin-to-muscle depth < 13 mm, which may increase the risk of anaphylaxis. The objective of this study was to determine whether the needle length of a standard allergy syringe is appropriate for patients receiving subcutaneous immunotherapy.Methods: Ultrasounds of the left posterolateral arm were performed to measure skin-to-muscle depth in 200 adults receiving subcutaneous immunotherapy. The proportion of patients with a skin-to-muscle depth > 13 mm vs. ≤13 mm was assessed and baseline characteristics of the two groups were compared. The proportion of patients with skin-to-muscle depths > 4 mm, 6 mm, 8 mm and 10 mm were also calculated. Multivariable logistic regression was performed to identify predictors of skin-to-muscle depth.Results: Of the 200 patients included in the study, 80% had a skin-to-muscle depth ≤13 mm; the majority (91%) had a skin-to-muscle depth > 4 mm. Body mass index was found to be a significant predictor of skin-to-muscle-depth.Conclusions: Most patients receiving subcutaneous immunotherapy have a skin-to-muscle depth less than the needle length of a standard allergy syringe (13 mm). These patients are at risk of receiving injections intramuscularly, which may increase the risk of anaphylaxis. Using a syringe with a needle length of 4 mm given at a 45° angle to the skin may decrease this risk. © 2014 Kim et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Kim, L., Nevis, I., Potts, R., Eeuwes, C., Dominic, A., & Kim, H. L. (2014). Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections. Allergy, Asthma and Clinical Immunology, 10(1). https://doi.org/10.1186/1710-1492-10-22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free